These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 9494773)

  • 1. Colposcopic evaluation of a vaginal gel formulation of iota-carrageenan.
    Elias CJ; Coggins C; Alvarez F; Brache V; Fraser IS; Lacarra M; Lähteenmäki P; Massai R; Mishell DR; Phillips DM; Salvatierra AM
    Contraception; 1997 Dec; 56(6):387-9. PubMed ID: 9494773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the vaginal tolerance to Acidform, an acid-buffering, bioadhesive gel.
    Amaral E; Faúndes A; Zaneveld L; Waller D; Garg S
    Contraception; 1999 Dec; 60(6):361-6. PubMed ID: 10715372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase I comparative study of three contraceptive vaginal films containing nonoxynol-9. Postcoital testing and colposcopy.
    Mauck CK; Baker JM; Barr SP; Johanson WM; Archer DF
    Contraception; 1997 Aug; 56(2):97-102. PubMed ID: 9315418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects.
    Stafford MK; Ward H; Flanagan A; Rosenstein IJ; Taylor-Robinson D; Smith JR; Weber J; Kitchen VS
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(4):327-31. PubMed ID: 9525433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaginal epithelial surface appearances in women using vaginal rings for contraception.
    Fraser IS; Lacarra M; Mishell DR; Alvarez F; Brache V; Lähteenmäki P; Elomaa K; Weisberg E; Nash HA
    Contraception; 2000 Feb; 61(2):131-8. PubMed ID: 10802278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I comparative study of contraceptive vaginal films containing benzalkonium chloride and nonoxynol-9. Postcoital testing and colposcopy.
    Mauck CK; Baker JM; Barr SP; Abercrombie TJ; Archer DF
    Contraception; 1997 Aug; 56(2):89-96. PubMed ID: 9315417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptability of a novel vaginal microbicide during a safety trial among low-risk women.
    Bentley ME; Morrow KM; Fullem A; Chesney MA; Horton SD; Rosenberg Z; Mayer KH
    Fam Plann Perspect; 2000; 32(4):184-8. PubMed ID: 10942354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary safety and acceptability of a carrageenan gel for possible use as a vaginal microbicide.
    Coggins C; Blanchard K; Alvarez F; Brache V; Weisberg E; Kilmarx PH; Lacarra M; Massai R; Mishell D; Salvatierra A; Witwatwongwana P; Elias C; Ellertson C
    Sex Transm Infect; 2000 Dec; 76(6):480-3. PubMed ID: 11221133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina.
    Mostad SB; Overbaugh J; DeVange DM; Welch MJ; Chohan B; Mandaliya K; Nyange P; Martin HL; Ndinya-Achola J; Bwayo JJ; Kreiss JK
    Lancet; 1997 Sep; 350(9082):922-7. PubMed ID: 9314871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary report of unexpected local reactions to a progestogen-releasing contraceptive vaginal ring.
    Bounds W; Szarewski A; Lowe D; Guillebaud J
    Eur J Obstet Gynecol Reprod Biol; 1993 Feb; 48(2):123-5. PubMed ID: 8491331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
    Coutinho EM; de Souza JC; da Silva AR; de Acosta OM; Alvarez F; Brache V; Garza Flores J; Vasquez-Estrada L; Santo R; Bassol S
    Clin Pharmacol Ther; 1993 Jan; 53(1):65-75. PubMed ID: 8422744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases.
    Roddy RE; Zekeng L; Ryan KA; Tamoufé U; Weir SS; Wong EL
    N Engl J Med; 1998 Aug; 339(8):504-10. PubMed ID: 9709043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current status of the female condom in Africa].
    Deniaud F
    Sante; 1997; 7(6):405-15. PubMed ID: 9503499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spermicidal and antiviral properties of cholic acid: contraceptive efficacy of a new vaginal sponge (Protectaid) containing sodium cholate.
    Psychoyos A; Creatsas G; Hassan E; Georgoulias V; Gravanis A
    Hum Reprod; 1993 Jun; 8(6):866-9. PubMed ID: 7688380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WHI-05, a novel bromo-methoxy substituted phenyl phosphate derivative of zidovudine, is a dual-action spermicide with potent anti-HIV activity.
    D'Cruz OJ; Zhu Z; Yiv SH; Chen CL; Waurzyniak B; Uckun FM
    Contraception; 1999 May; 59(5):319-31. PubMed ID: 10494486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of frequent nonoxynol-9 use on the vaginal and cervical mucosa.
    Niruthisard S; Roddy RE; Chutivongse S
    Sex Transm Dis; 1991; 18(3):176-9. PubMed ID: 1658953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical development of microbicides for the prevention of HIV infection.
    D'Cruz OJ; Uckun FM
    Curr Pharm Des; 2004; 10(3):315-36. PubMed ID: 14754390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of vaginally administered nonoxynol-9 in premenopausal women.
    Barditch-Crovo P; Witter F; Hamzeh F; McPherson J; Stratton P; Alexander NJ; Trapnell CB
    Contraception; 1997 Apr; 55(4):261-3. PubMed ID: 9179459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contraception and the prevention of sexually transmitted diseases.
    Kirkman R; Chantler E
    Br Med Bull; 1993 Jan; 49(1):171-81. PubMed ID: 8324607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boost for vaginal microbicides against HIV.
    Lange JM; Karam M; Piot P
    Lancet; 1993 Nov; 342(8883):1356. PubMed ID: 7901643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.